186 related articles for article (PubMed ID: 31125629)
1. Association between cannabis laws and opioid prescriptions among privately insured adults in the US.
Raji MA; Abara NO; Salameh H; Westra JR; Kuo YF
Prev Med; 2019 Aug; 125():62-68. PubMed ID: 31125629
[TBL] [Abstract][Full Text] [Related]
2. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
Wen H; Hockenberry JM
JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
[TBL] [Abstract][Full Text] [Related]
3. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
[TBL] [Abstract][Full Text] [Related]
4. The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance.
Wen J; Wen H; Butler JS; Talbert JC
Health Econ; 2021 May; 30(5):989-1000. PubMed ID: 33624387
[TBL] [Abstract][Full Text] [Related]
5. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
Lopez CD; Boddapati V; Jobin CM; Hickernell TR
J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
[TBL] [Abstract][Full Text] [Related]
6. Association Between State Opioid Prescribing Cap Laws and Receipt of Opioid Prescriptions Among Children and Adolescents.
Stone EM; Tormohlen KN; McCourt AD; Schmid I; Stuart EA; Davis CS; Bicket MC; McGinty EE
JAMA Health Forum; 2022 Aug; 3(8):e222461. PubMed ID: 36003417
[TBL] [Abstract][Full Text] [Related]
7. Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain.
McGinty EE; Tormohlen KN; Seewald NJ; Bicket MC; McCourt AD; Rutkow L; White SA; Stuart EA
Ann Intern Med; 2023 Jul; 176(7):904-912. PubMed ID: 37399549
[TBL] [Abstract][Full Text] [Related]
8. Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder.
Segura LE; Mauro CM; Levy NS; Khauli N; Philbin MM; Mauro PM; Martins SS
JAMA Netw Open; 2019 Jul; 2(7):e197216. PubMed ID: 31314118
[TBL] [Abstract][Full Text] [Related]
9. Opioid prescribing rates from the emergency department: Down but not out.
Ali MM; Cutler E; Mutter R; Henke RM; Mazer-Amirshahi M; Pines JM; Cummings N
Drug Alcohol Depend; 2019 Dec; 205():107636. PubMed ID: 31704377
[TBL] [Abstract][Full Text] [Related]
10. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
Nguyen HV; McGinty EE; Mital S; Alexander GC
JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
[TBL] [Abstract][Full Text] [Related]
11. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
Bachhuber MA; Saloner B; Cunningham CO; Barry CL
JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
[TBL] [Abstract][Full Text] [Related]
12. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
13. Recreational cannabis and opioid distribution.
Raman S; Maclean JC; Bradford WD; Drake C
Health Econ; 2023 Apr; 32(4):747-754. PubMed ID: 36653623
[TBL] [Abstract][Full Text] [Related]
14. Opioid Prescription Patterns Among US Gastroenterologists From 2013 to 2017.
Chen FW; LeBrett WG; Yang L; Chang L
Gastroenterology; 2020 Feb; 158(3):776-779.e2. PubMed ID: 31647903
[No Abstract] [Full Text] [Related]
15. State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users.
Calabrese MJ; Shaya FT; Palumbo F; McPherson ML; Villalonga-Olives E; Zafari Z; Mutter R
J Opioid Manag; 2024; 20(2):149-168. PubMed ID: 38700395
[TBL] [Abstract][Full Text] [Related]
16. Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data.
Prunuske JP; St Hill CA; Hager KD; Lemieux AM; Swanoski MT; Anderson GW; Lutfiyya MN
BMC Health Serv Res; 2014 Nov; 14():563. PubMed ID: 25407745
[TBL] [Abstract][Full Text] [Related]
17. Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing.
Jones CM; Lurie PG; Throckmorton DC
JAMA Intern Med; 2016 Mar; 176(3):399-402. PubMed ID: 26809459
[No Abstract] [Full Text] [Related]
18. Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012-2017.
Zhu W; Chernew ME; Sherry TB; Maestas N
N Engl J Med; 2019 Mar; 380(11):1043-1052. PubMed ID: 30865798
[TBL] [Abstract][Full Text] [Related]
19. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
[TBL] [Abstract][Full Text] [Related]
20. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.
Chang HY; Lyapustina T; Rutkow L; Daubresse M; Richey M; Faul M; Stuart EA; Alexander GC
Drug Alcohol Depend; 2016 Aug; 165():1-8. PubMed ID: 27264166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
